Articles tagged with "Treatment"

Why Antiphospholipid Antibody Syndrome Should Be On Your Radar

Imad Uthman, MD, MPH, and Munther Khamashta, MD, PhD | February 1, 2014

With a wide range of clinical manifestations and frequent occurrence among rheumatology patients, APS is one for rheumatologists to watch

Childhood-onset Lupus Brings Distinct Challenges at Each Phase of Life

Deborah M. Levy, MD, MS | January 1, 2014

Differences in disease manifestations, severity, and management require special consideration from rheumatologists who treat children and adolescents with systemic lupus erythematosus

Inflammatory Myopathies Difficult to Diagnose, Treat

Jonathan Jones, MD, and Robert Wortmann, MD | December 1, 2013

Without a single set of diagnostic criteria for identifying polymyositis, dermatomyositis, or myositis and scant evidence-based therapeutic guidelines, these rare muscle diseases can be hard to manage

2013 ACR/ARHP Annual Meeting: The Rheumatoid Arthritis Treatment Debate

Mary Beth Nierengarten | December 1, 2013

Discussion by rheumatologists on the merits of biologics vs. triple therapy for patients with RA lends insight into therapeutic alternatives

2013 ACR/ARHP Annual Meeting: Rheumatology Year in Review

Mary Beth Nierengarten | December 1, 2013

Progress in treatments for pediatric rheumatic diseases, collaborative clinical trials, and personalized therapeutic approaches highlight the past year in rheumatology

Fellow’s Forum Case Report: New Sarcoidosis Cases in Patients Treated with Tumor Necrosis Factor–Alpha Inhibitors

Jonida Cote, DO, Thomas Harrington, MD, Alicia Meadows, DO, Fan Lin, MD, and Androniki Bili, MD, MPH | November 1, 2013

Two patients with psoriatic arthritis treated with TNF-alpha inhibitor therapy develop the multisystem disease

New Insights into CPPD

Robert Terkeltaub, MD | October 1, 2013

Progress in research, outcomes, diagnosis, and treatment of calcium pyrophosphate dihydrate crystal deposition disease

Tech Talk: New Technologies Attempt to Find Better Treatments for Rheumatic Diseases

Thomas R. Collins | September 1, 2013

Research in proteomics and genetics sheds new light on treatment strategies, brings potential for breakthroughs

EULAR 2013: Researchers Make Inroads in Treatment of Osteoarthritis

Thomas R. Collins | September 1, 2013

Experts discuss evidence-based benefits of knee joint distraction and the progress being made in harnessing the effects of stem cells

EULAR 2013: Tips for Managing Peripheral Neuropathy in Rheumatic Disease

Thomas R. Collins | September 1, 2013

How to determine which tests to order, how to interpret them, and how to decide on the right treatment course